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Peptidoglycan (PG) is an essential component in the cell wall of nearly all
bacteria, forming a continuous, mesh-like structure, called the sacculus,
around the cytoplasmic membrane to protect the cell from bursting by its
turgor. Although PG synthases, the penicillin-binding proteins (PBPs), have
been studied for 70 years, useful in vitro assays for measuring their activities
were established only recently, and these provided the first insights into the
regulation of these enzymes. Here, we review the current knowledge on the
glycosyltransferase and transpeptidase activities of PG synthases. We provide
new data showing that the bifunctional PBP1A and PBP1B from Escherichia coli
are active upon reconstitution into the membrane environment of proteolipo-
somes, and that these enzymes also exhibit DD-carboxypeptidase activity in
certain conditions. Both novel features are relevant for their functioning
within the cell. We also review recent data on the impact of protein–protein
interactions and other factors on the activities of PBPs. As an example, we
demonstrate a synergistic effect of multiple protein–protein interactions on
the glycosyltransferase activity of PBP1B, by its cognate lipoprotein activator
LpoB and the essential cell division protein FtsN.1. Introduction
Peptidoglycan (PG) is a key cell wall component in nearly all bacteria, protect-
ing the cell from bursting by its internal turgor and maintaining cell shape [1].
PG consists of glycan strands connected by short peptides and forms a continu-
ous, mesh-like structure around the cytoplasmic membrane, called the sacculus
[2]. In Gram-negative species, such as Escherichia coli, the sacculus is made of a
mainly single layer of PG with a thickness of 3–6 nm, whereas in Gram-positive
species, a multi-layered PG is much thicker at 10–20 nm [3]. The glycan strands
are made of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic
acid (MurNAc) residues linked by b-1,4 glyosidic bonds. The peptides contain
L- and D-amino acids and are linked to MurNAc residues, the sequence varying
across bacterial species. In E. coli and most other Gram-negative species, the
peptide sequence is as follows: L-Ala-D-iGlu-m-Dap-D-Ala-D-Ala (m-Dap,
meso-diaminopimelic acid). Peptides protruding from adjacent glycan strands
may be connected, most often from the carboxyl group of D-Ala at position 4
of one peptide to the 1-amino group of the m-Dap residue at position 3 of
another peptide (3–4 or DD-cross-link).
During cell growth and division, the surface of the sacculus is enlarged by
the incorporation of new PGmaterial. In this process, the precursor lipid II (unde-
caprenyl-pyrophosphoryl-MurNAc(pentapeptide)-GlcNAc) is polymerized by
glycosyltransferase (GTase) reactions, under the release of undecaprenol pyro-
phosphate, and peptide cross-links are formed by transpeptidase (TPase)
reactions (figure 1a). TPase involves a donor pentapeptide, which loses its car-
boxy-terminal D-alanine residue in the course of the reaction, and an acceptor
peptide with a free amino group [4]. TPase reactions connect peptides between
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Figure 1. Reactions and domain organization of class A and class B PBPs. (a) Peptidoglycan synthesis and peptide cleavage reactions. A nascent glycan strand is
synthesized from lipid II precursor by glycosyltransferase (GTase) reactions under the release of the undecaprenol pyrophosphate moiety (indicated by the zigzag line
and two red dots). Peptide cross-links are formed by DD-transpeptidase (TPase) reactions catalysed by penicillin-binding proteins (PBPs), forming 4–3 cross-links.
Some PBPs are also capable of hydrolysing the terminal D-alanine residue of the pentapeptide stem through DD-carboxypeptidase (CPase) activity, or hydrolysing the
4–3 cross-link through DD-endopeptidase (EPase) activity. (b) Crystal structures of E. coli PBP1B and PBP3. The bifunctional PBP1B (PDB ID: 3FWM) and the TPase
PBP3 (PDB ID: 4BJP) anchor to the inner membrane (IM). The GTase domain of PBP1B is shown in blue, the TPase domains of both proteins are shown in green. The
non-catalytic/regulatory domains such as the UB2H domain of PBP1B or the N-terminal module of PBP3 are shown in wheat. The residues essential for catalytic
activity in each domain are labelled in red.
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in new strands and old ones in the sacculus; the latter attaches
the new PG to the sacculus. PG hydrolases are required to open
the PG net allowing the insertion of the newly attached PG into
the stress-bearing layer and sacculus growth. Presumably, PG
growth is facilitated by dynamic multi-enzyme complexes
that contain all the enzymatic activities required, and that are
tightly regulated and coordinated with cell growth [5,6].
PG synthases have a modular structure and are classified
according to their activity [4,7]. Class A penicillin-binding pro-
teins (PBPs) are bifunctional enzymes with both GTase and
TPase activity, whereas class B PBPs and Mgt enzymes are
monofunctional TPases and GTases, respectively. Class A
and class B PBPs are anchored to the cytoplasmic membrane
by a single transmembrane region near their N-terminus.
Most of them also have non-catalytic domains of which some
are involved in interactions with other proteins to regulate
the enzymatic activities (figure 1b) [8]. The abundant PG
hydrolases come with different specificities for cleavage in
PG and have a number of cellular roles [9]. Class C PBPs are
PG hydrolases with DD-carboxypeptidase (CPase) or endo-
peptidase (EPase) activity (figure 1a). EPases cleave the
peptide cross-links, and CPases trim the peptides in the PG
by hydrolysing the terminal amino acid residue.
Here, we provide a brief overview of the pioneering work
in the past century on the activities of PG synthases. We then
review the current knowledge on the activities of these
enzymes studied by in vitro PG synthesis assays. This work
was only possible after optimizing the isolation of the enzymes
and the substrate, lipid II. We also present previously unpub-
lished data demonstrating that PBP1A and PBP1B from
E. coli are active when reconstituted into proteoliposomes,
and that both enzymes exhibit DD-CPase activity under certain
conditions. Another main focus is how multiple interactions
with other proteins regulate the activities of PBPs, to ensurecoordination of PG growth with cell growth and other cellular
processes, such as outer membrane (OM) constriction. In line
with this, we also present previously unpublished data demon-
strating a synergistic stimulatory effect of two binding partners
on the GTase activity of PBP1B.2. Early work on the activities of peptidoglycan
synthases
Here, we provide a brief overview of the early work on the
activities of PG synthases, which is not complete and not
always in a chronological order. Historically, the work on
PG synthases began after it became clear that penicillin, the
powerful antibiotic discovered by Alexander Fleming in
1929 [10], is a specific inhibitor of bacterial cell wall synthesis
[11–13]. With the knowledge of the chemical structure of the
PG precursors [14] and the basic subunits present within
the high-molecular PG [15], it became clear that the final
step in PG synthesis requires two enzymatic activities, glyco-
syltransferase (GTase, or transglycosylation) reactions for
glycan strand polymerization and transpeptidation (TPase)
for peptide cross-linking. Further early studies revealed that
penicillin treatment resulted in the inhibition of TPase result-
ing in the formation of uncross-linked PG [16–18]. To the best
of our knowledge, in vitro PG synthesis reactions were first
demonstrated in the year 1966 when Izaki et al. [19] used
radiolabelled UDP-MurNAc-pentapeptide as substrate for a
crude enzyme preparation (possibly a membrane extract)
from E. coli and obtained high-molecular weight products
under release of D-Ala. This and further studies from the Stro-
minger laboratory with membrane fractions from E. coli
helped to elucidate the mechanism of the TPase reaction
and the mode of action of penicillin.
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tigated. Initial work showed that membrane fractions from
Staphylococcus aureus and Micrococcus luteus produced linear,
uncross-linked glycan strands [20,21], but subsequent studies
using a cellwall–membrane complex from these species demon-
strated both GTase and TPase activities [22,23]. This suggested
that in these reactions the cross-linking occurredmainly between
peptides of the newlymade PG and peptides in the pre-existing
cell wall. Other work provided evidence for PG synthesis
activity and its inhibition by various antibiotics in membranes
or membrane extracts fromGaffkya homari [24,25], Bacillus mega-
terium [26] and E. coli [27–30]. Cell membranes from E. coliwere
also used to assay the TPase activity of PBP2,which is selectively
inhibited by the b-lactam mecillinam [31].
PG synthesis reactions can also be performed in cells of
E. coli or other bacteria that were treated with ether, which
increases the permeability of the cytoplasmic membrane
permitting the access of extracellular, radiolabelled precursors
to other cellular precursors and enzymes [32]. The radiolabelled
compound can be meso-diaminopimelic acid (m-Dap) or UDP-
MurNAc-pentapeptide, and the detection of the product
occurs by hydrolysis with a muramidase followed by paper
or high-pressure liquid chromatography. The technique
showed the synthesis of PG in ether-treated cells of Proteus mir-
abilis [33] and E. coli [34–36]. In the latter, two types of TPase
reactions were observed, presumably by enzymes that differed
in their sensitivity to penicillin G and capability to form hyper-
cross-linked PG versus cross-links between two peptides only
(to form peptide dimers) [35].
The study of in vitro activities of DD-transpeptidases can
be cumbersome as most of these enzymes are membrane-
anchored and difficult to purify in sufficient quantity for
biochemical work, and they require ongoing glycosyltransfer-
ase activity and/or complex substrates (see below). A set of
enzymes from Streptomyces strains became early models to
study transpeptidation because they were water-soluble and
used small, soluble peptides as substrates. These were the
DD-carboxy-/transpeptidases from the Streptomyces strains
R61, K11 and R39. These enzymes can use the small donor
diacetyl-L-lysine-D-alanine-D-alanine (with radioactive label
at the acetyl groups) for transpeptidation reactions with a
variety of possible acceptors, which could be glycine, D-(but
not L-) amino acids such as D-alanine or m-Dap, or di- or
oligo-peptides containing glycine or D-alanine [37]. Further
work characterized the kinetics of the TPase and hydrolase
(carboxypeptidase, CPase) activities, and determined the
specificity of the TPase enzymes regarding the acceptor pep-
tides that resembled structures found in the PG [38–40].
The lipid intermediates in PG synthesis (lipid I and lipid II)
were identified by the mid-1960s [41,42], but possibly owing to
their limited availability and the lack of purified enzymes it
took some time until lipid II was used as substrate for PG syn-
thesis reactions. The laboratory of MichioMatsuashi pioneered
the semi-purification of peptidoglycan synthases (PBPs) via
binding to ampicillin–sepharose, followed by elution of the
proteins with hydroxylamine and activity assays with lipid II
substrate [43]. The selectivity for certain synthases was
achieved by using mutant strains overexpressing or depleting
some of the PBPs. This impressive work led to the first charac-
terization of the bi-functional PBPs from E. coli, PBP1A [44] and
PBP1B [43], showing the time-course of lipid II consumption
and formation of PG, as well as the antibiotic inhibition of
GTase and TPase by measuring the extent of cross-linkage inthe product formed [45,46]. This approachwas also undertaken
to measure the activity of PBP3 from E. coli, a monofunctional
transpeptidase. However, this work reported GTase and TPase
activity for PBP3 [47], suggesting that the PBP3 preparation
contained a contaminating GTase activity, presumably the
bifunctional PBP1B which is now known to interact with
PBP3 [48]. Consistent with this, a second study with semi-pur-
ified PBPs detected PG synthesis activity for PBP1A and
PBP1B, but not for PBP3 alone [49]. Using lipid II as substrate,
various purified enzymes from Gram-positive Bacillus species
were also assayed. These produced uncross-linked or poorly
cross-linked PG [50,51]. Presumably, the TPase efficiency was
low in these experiments, because, as we know now, some
enzymes from Gram-positive species require amidated lipid
II substrate (see below) which was not available in the 1980s.
PG biosynthesis is a validated target for antibiotics. The
highly successful class of b-lactam antibiotics inhibits the
TPase, but there are only few known inhibitors of the essential
GTase reactions, for example the lipid II analoguemoenomycin
(flavomycin). Several ‘crude’ assays were established to screen
for GTase inhibitors, using cell membrane (extract) without
purifying the enzymes. One of these assays uses cell extract
from a MurG overexpressing E. coli strain and UDP-MurNAc
pentapeptide from Enterococcus faecium, which harbours an
L-lysine residue at position 3 and is therefore not a substrate
for the E. coli TPase [52]. The addition of radiolabelled UDP-
GlcNAc initiates the synthesis of lipid II which is used by
the E. coli GTases to produce uncross-linked glycan strands;
these can be quantified by paper chromatography where they
remain at the start spot. Another, rather simple assay for
GTase inhibitors is based on a competition with moenomycin
for binding to the active site [53]. For this assay, the bifunctional
PBP1AandPBP1Bpresent in crudeE. colimembrane extract (of
wild-type or mutant strains) are labelled with a radioactive
or fluorescent b-lactam. This extract is incubated with beads
containing coupled moenomycin in the wells of a filter micro-
plate, followed by washing and quantification of the bound
PBPs by scintillation counting or fluorescence measurements.
Compounds binding to the GTase active site compete with
moenomycin thereby reducing the signal.
In the following sections, we provide an overview on the
methods to isolate lipid II, the currently used in vitro PG syn-
thesis assays using lipid II or its derivatives as substrate, and
the major findings on the GTase and TPase reactions obtained
with these assays.3. Isolation of lipid II for in vitro assays
(a) Unlabelled lipid II
The partial or total chemical synthesis of lipid II has been
described [54–56]. However, the biochemical production of
lipid II is easier and more feasible for non-chemists. There-
fore, we focus in this review on the available biochemical
methods of obtaining (labelled) lipid II (figure 2).
The biochemical production of lipid II requires four com-
ponents, the lipid carrier undecaprenyl phosphate (11-p),
UDP-MurNAc-pentapeptide, UDP-GlcNAc and the enzymes
catalysing the formation of lipid II from these substrates,
MraY and MurG (figure 2a). For a long time, the bottleneck in
the (bio)chemical production of lipid II has been the
availability of the lipid tail of lipid II, which is a phosphorylated
C55 isoprenoid alcohol (made of 11 prenoid units), also called
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Figure 2. Synthesis of lipid II. (a) Schematic of the membrane-associated steps of lipid II synthesis. UDP-MurNAc-pentapeptide is attached to the lipid carrier
undecaprenol phosphate by MraY creating lipid I. Next, UDP-GlcNAc is attached to lipid I by MurG creating lipid II, which can be modified at different positions
as described in the text. (b) Undecaprenol can be extracted from leaves of Laurus nobilis using a mixture of acetone and hexane, followed by purification over a silica
column and, if a uniform chain length is needed, by reversed-phase high-pressure liquid chromatography (HPLC). (c) UDP-MurNAc-pentapeptide can be extracted
from Bacillus cereus ( for the m-Dap version) or Staphylococcus simulans (L-lysine version) by blocking cell wall synthesis with vancomycin and subsequent boiling of
the cells in water, centrifugation and lyophilization of the UDP-MurNAc-pentapeptide supernatant. (d ) MraY and MurG are present in membranes from Micrococcus
flavus, which are lysed and centrifuged to obtain the membrane vesicles in the supernatant. (e) To produce lipid II, all components are incubated for 2–4 h at room
temperature, lipids are extracted using butanol/pyridine at pH 4.2, and lipid II is purified over a DEAE cellulose column.
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and -negative bacteria [42,57]. The early protocols for the bio-
chemical lipid II synthesis used membrane vesicles from
Gram-positive bacteria as the source of this lipid, and these ves-
icles also provided the MraY and MurG [58,59]. However,
although membranes from Gram-positive bacteria contain
more undecaprenyl phosphate than those fromGram-negatives
[60], the cellular pool is small because it is constantly being
recycled during the cell wall synthesis cycle, limiting the
amount bacteria need for growth [61,62]. As a result, to
obtain approximately 150 mg undecaprenyl phosphate, large
amounts of membranes and reaction/extraction volumes (1 l)
and large anion exchange column sizes (2.5  25 cm) were
needed for the production, extraction and purification of lipid
II [59]. The yield of lipid II in the biochemical synthesis could
be considerably improved (by at least a factor of 100) by the
addition of purified undecaprenyl phosphate [63]. Moreover,
the substrate specificity ofMraY for polyisoprenoid phosphates
turned out to be so broad that lipid II variants could be pre-
pared with polyisoprene tails that vary from two to more
than 20 isoprene units [63].
Plant leaves are the best source for polyisoprenoids [64], and
there are two easily accessible sources for undecaprenol: bay
leaves and leaves from the Staghorn sumac (Rhus typhia), an indi-
genous plant in North America and ornamental in Europe. The
extraction and purification of undecaprenol from plant leaves is
relatively straightforward [65,66]. Ground leaves are extracted
with a mixture of acetone and hexane followed by silica
column purification. The prenols are present in a mixture of
polyisoprenoids of 10, 11 and 12 isoprene units. A uniform pre-
noid length can be obtained in a second purification step using
reversed-phase high-pressure liquid chromatography (HPLC;
figure 2b). Subsequent phosphorylation to the polyprenol
phosphate can be performed in a single step [67].
UDP-GlcNAc can be purchased from different chemical
supply companies. UDP-MurNAc pentapeptide is extracted
from bacteria and its source is dependent on the chemical ver-
sion of lipid II that is desired. Bacillus cereus and Staphylococcus
simulans are the best sources for the extraction of the lipid II
versions with m-Dap and L-lysine, respectively [1]. The extrac-
tion of UDP-MurNAc pentapeptide (figure 2c) is based on its
cellular accumulation upon inhibition of cell wall synthesis by
vancomycin [68]. UDP-MurNAc pentapeptide is extracted by
boiling the cells inwater followed by centrifugation and lyophi-
lization of the supernatant. This UDP-MurNAc pentapeptide-
containing extract can directly be used for the synthesis of
lipid II without further purification.
The enzymes MraY and MurG can come from various
sources ranging from the purified enzymes to isolated bacterial
membranes from Gram-positive bacteria or E. coli cells overex-
pressing the twoproteins [69].Membranes fromGram-positive
bacteria are easiest to work with, and most often Micrococcus
flavus membranes are used (figure 2d). However, some mem-
brane preparations lack sufficient MurG activity; this is the
case formembranes fromBacillus subtiliswhich only synthesize
lipid I (E. Breukink, unpublished data).
To finally produce lipid II, the four components men-
tioned above are mixed in a detergent containing buffer
and stirred for 2–4 h at room temperature (figure 2e). Lipid
II is extracted with butanol/pyridine at pH 4.2 according to
the procedure originally developed by Strominger and co-
workers [58] and is further purified in one step using a
small anion exchange column [63].(b) Labelled lipid II
In order to track lipid II or the products formed by
PG synthases in functional assays (see below), fluorescent
groups or radioactive isotopes can be incorporated in the
UDP-MurNAc pentapeptide and/or UDP-GlcNAc moieties.
Fluorescent labelling of lipid II can be achieved by the
incorporation of fluorescently labelled UDP-MurNAc penta-
peptide which, for example, contains a pyrene [63], a
dansyl [70] or a 7-nitro-2,1,3-benzoxadiazol-4-yl label [71].
This approach requires purification of the L-lysine version of
UDP-MurNAc pentapeptide which can be labelled at the 1-
amino group of L-Lys followed by purification of the labelled
precursor [63,70]. However, this approach is rather inefficient
as the labelled UDP-MurNAc pentapeptide is used in excess
during the synthesis of labelled lipid II. Novel approaches
using the biorthogonal click chemistry significantly increase
the efficiency of labelling. For this, the amino group of the
lysine residue of lipid II was converted into an azide via the
incubation with imidazole-1-sulfonyl azide hydrochloride,
which acts as a diazo donor in the conversion of primary
amines into azides [72]. The azido-lipid II is extracted and pur-
ified from the reactionmixture, and can then be used in (copper
catalysed) click reactions with azide or cyclooctyne containing
fluorophore labels.
Radiolabelled UDP-GlcNAc can also be incorporated into
lipid II [70]. While producing radiolabelled lipid II using
[14C]-GlcNAc, it was observed that MurG is able to exchange
the GlcNAc of the lipid II head group with GlcNAc of UDP-
GlcNAc. This property has been used to obtain lipid II with a
radiolabelled GlcNAc by a simple exchange reaction using
purified lipid II and [14C]-GlcNAc in the presence of MurG
(E. Breukink, unpublished data).
(c) Biological variants of lipid II
Next to the variation in the amino acid composition of the pen-
tapeptide, some bacteria modify one or more of the carboxylic
groups of the stem peptide by amidation [1]. In S. aureus, the
MurT/GatD complex amidates the D-Glu residue [73,74], and
in B. subtilis AsnB amidates the carboxylic group of m-Dap
(van Bentum and Breukink, unpublished data). Lipid II ver-
sions carrying these amidations can be generated in vitro by
incubating lipid II in the presence of amidating enzymes,
ATP and an amido group donor such as glutamine or even
ammonia [75].
Peptide branches linked to position 3 of the stem peptide
are another example of species-specific modification of lipid
II. These branches are made of one to seven amino acids; a
well-known version is the pentaglycine peptide present in
the PG of S. aureus. In this species, the peptide branch is
attached to lipid II by the successive action of the Fem trans-
ferases, FemX, FemA and FemB, that use amino acid loaded
t-RNAs as substrates [76]. FemX attaches the first glycine resi-
due to lipid II, the second and third residue are attached by
FemA, which recognizes only lipid II with a previously
attached first glycine residue. The last two glycine residues
are attached by FemB, which also has acceptor specificity
and only uses lipid II with three glycine residues attached.
The attachment of the branch to lipid II has been achieved
in vitro using purified lipid II and enzymes [77]. A similar
system has been shown to exist for the bacterium Weissella
viridescens, in which Fem enzymes use UDP-MurNAc penta-
peptide as the substrate for the attachment of the first alanine
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Figure 3. Schemes of the currently used PG synthesis activity assays. (a) Separation of glycan strands by SDS–PAGE. (b) Continuous GTase assay with dansylated
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of lipid II by unknown Fem-like proteins. The first step of this
process has been reconstituted in vitro [78].
The synthesis of significant amounts of native, unmodi-
fied or modified lipid II or of versions carrying reporter
groups has provided essential tools for studying the PG
synthesis pathway and generated crucial knowledge about
the enzymes involved and their regulation. Examples for
the successful use of lipid II versions are outlined below.4. Processivity and substrate specificity of GTases
Figure 3 summarizes the currently often used in vitro PG syn-
thesis assays. PG GTases belong to the glycosyltransferase
family 51 (GT51) [79] and polymerize lipid II to produce
glycan strands that, in the absence of TPase activity, contain
an uncross-linked pentapeptide at each MurNAc residue.
When testing bifunctional GTase/TPases, uncross-linked
glycan strands can be obtained by the addition of a b-lactam
antibiotic. Lipid II and glycan strands containing two to
approximately 20 disaccharide units can be separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) [80] (figure 3a). Higher oligomers are usually
not separated. If the lipid II substrate is radiolabelled, the pro-
ducts of the reaction separated by SDS–PAGE can be detected
by autoradiography of the dried gel, and the bands can be
quantified by densitometric analysis.
The glycan strand grows by the addition of the next
subunit to the MurNAc end of the growing strand, whereby
the growing glycan strand serves as donor and the next lipid
II as acceptor in the reaction [81–83]. This is consistent withcrystal structures showing the donor and acceptor binding
sites [79,84]. Analysis of the time-course of GTase reactions
suggest that the enzymes work processively, i.e. the growing
glycan strand remains at the enzyme active site until it is fully
polymerized and released. When starting with lipid II, the
initiation of the reaction requires the simultaneous binding
of two lipid II molecules to the acceptor and donor sites of
the GTase. Following the first GTase reaction and upon
release of the undecaprenol pyrophosphate, the tetrasacchar-
ide product moves into the enzyme’s donor site allowing the
binding of the next lipid II into the acceptor site and the next
GTase reaction to proceed, yielding the hexasaccharide. These
processive GTase reactions are faster than the initiation of the
reaction with two lipid II molecules. Tetrasaccharide- and hex-
asaccharide-containing precursors (lipid IV or lipid VI) are
poor or no substrates on their own, but can be incorporated
into higher oligomers when lipid II is polymerized [80,85]. It
has been recently shown for the monofunctional S. aureus
GTase MtgA that a low concentration of lipid II (binding to
the acceptor site) increases the binding affinity of moenomycin
to the donor site, indicating an allosteric activation of the donor
site and positive cooperativity between both sites [86].
Different GTases differ in their processivity resulting in
glycan strands with different length distribution. PBP1A
from Aquifex aeolicus produces long glycan strands as does
PBP1A from E. coli, but the distribution of the latter is nar-
rower. A series of A. aeolicus PBP1A single point mutants
differed significantly in the extent of lipid II conversion and
product length distribution and allowed the identification
of amino acid residues crucial for GTase activity [80]. The
bifunctional GTase/TPase PBP2 from S. aureus was found
to be mutated after selection for increased sensitivity to
rstb.royalsocietypublishing
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(Y196D) produced shorter glycan strands in vitro. In the
cell, the defective GTase of PBP2(Y196D) needs to be compen-
sated by the presence and activity of the monofunctional
GTase SgtB. Hence, presumably the two PG synthases
cooperate in the cell, and this cooperation is essential in the
presence of the mutated PBP2 to produce glycan strands of
appropriate length and cross-link these through PBP2’s
TPase activity [87]..org
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Using radioactive- or fluorescence-labelled lipid II permitted
the kinetic characterization of some GTases. PBP2 from
S. aureus was most active at pH 5.0 and with radiolabelled
lipid II displayed a Km of 4 mM, kcat of 0.015 s
21 and kcat/Km
of 3400 M21 s21 [88]. The S. aureus monofunctional GTase
Mgt (also termed MtgA) becomes essential in the absence of
PBP2 and has similar kinetic properties to PBP2 [89,90]. Com-
pared with these enzymes, the bifunctional GTase/TPases
PBP4 from Listeria monocytogenes and PBP1B from E. coli had
either lower or higher efficiency (PBP4: 1400 M21 s21; PBP1B:
39 000 M21 s21) [91,92].
A major breakthrough in GTase assays came from the
development of a continuous assay using fluorescent dansyl-
lipid II (the dansyl group resides at the 1-amino group of
lysine at position 3 of the peptide) [93]. In this assay, polymer-
ization of dansyl-lipid II to glycan strands followed by their
digestion with a muramidase (such as mutanolysin or cellosyl)
results in the formation of dansylated muropeptide that shows
a lower fluorescence than the lipid II substrate owing to the
reduced fluorescence intensity of the dansyl group upon
removal of the lipid moiety (figure 3b). Hence, the progression
of the GTase reaction can be followed by the reduction in fluor-
escence over time. The assay was first used to characterize
PBP1B, demonstrating its pH optimum at pH 8.5–9.5, the
effect of detergents, DMSO and divalent cations on GTase
rate, and determining the catalytic constants. However, the
caveat with this study is that the source of PBP1B is not clear.
While the title and results section designates it as E. coli
PBP1B, the methods section reports that it was the PBP1b
gene from Streptococcus pneumoniae which was overexpressed
and purified from E. coli [54,93]. So far, we have been unable
to obtain information from the authors to clarify the nature of
the enzyme used in these studies. The continuous GTase
assay was later modified for use with a microplate reader for
higher sample throughput [94]. This allowed a screen for the
optimal detergent and DMSO concentrations for PBP1a from
Thermotoga maritima, which was also shown to produce signifi-
cantly shorter glycan strands than E. coli PBP1B using the
SDS–PAGE system to analyse the products of radiolabelled
lipid II [94]. Purified PBP2a from S. pneumoniae was active
with fluorescent dansyl-lipid II with some but not all tested
detergents, and the products could be analysed by SDS–
PAGE (replacing the use of radiolabelled lipid II) [95]. Interest-
ingly, this work also showed that a truncated version of PBP2a
lacking the membrane anchor was severely affected in GTase
activity, producing shorter glycan strands, indicating that the
transmembrane region is crucial for GTase activity. This con-
tinuous assay is particularly useful to evaluate the relative
effect of interaction partners on the activity of E. coli GTases
which will be described below.6. Measurement of TPase activity
TPase reactions lead to the formation of peptide cross-links
under the release of D-alanine and are catalysed by class A
and class B PBPs. The reaction requires a pentapeptide donor
that loses the terminal D-alanine residue resulting in an inter-
mediary tetrapeptide bound to the catalytic serine of the PBP.
Nucleophilic attack of an amino group of the acceptor peptide
resolves the intermediate and generates the new peptide bond.
The acceptor can, in principle, be a tri-, tetra- or pentapeptide
with or without a branch at position 3, and can be either a
monomer or an already cross-linked peptide. In the latter
case,multimeric peptide cross-links (such as trimers, tetramers,
etc.) are produced. Depending on the reaction conditions, some
TPases also accept a water molecule as acceptor, acting as a
carboxypeptidase (CPase) to trim the pentapeptide donor to
a tetrapeptide (see below). Hence, the release of D-alanine
alone cannot distinguish between TPase and CPase activity,
and the cross-linked transpeptidation product needs to be
detected to unambiguously prove TPase activity.
Apart from lipid II, TPases can use other substrates such as
peptide or thiolester donors, and D-amino acid acceptors, which
are mainly used for kinetic characterization. In these TPase
exchange reactions, the donor (benzoyl-Gly-thiolactate or ben-
zoyl-Gly-glycolate) or a peptide with a D-alanyl-D-alanine
terminus reacts with a D-amino acid acceptor (often D-alanine)
followed by quantification of the products [27,91,96]. GTase/
TPases incorporated D-amino acids even in the presence of
lipid II, i.e. they perform transpeptidation reactions with
D-amino acids under the release of D-alanine, incorporating
the other D-amino acid. If the added amino acid is radiolabelled
D-alanine and lipid II is not, radioactivity becomes incorporated
into the pentapeptides of the newlymadePG (figure 3c).Hence,
the incorporation of radiolabelled D-alanine or D-tryptophan
has been used to detect or quantify TPase activity [97–99].
Interestingly, fluorescence labelled D-amino acids can be incor-
porated into the PG of live bacteria during growth allowing the
visualization of the incorporation sites and determination of the
modes of PG growth in a variety of bacterial species [100–102].
In a bacterial cell, GTases and TPases use lipid II to syn-
thesize a high-molecular weight PG product. This reaction has
been reconstituted in vitro, followedby theanalysis of the compo-
sition of the PG synthesized [103,104]. For this, the reaction of a
PG synthase with radiolabelled lipid II is stopped by boiling at
mild acidic pH, which also hydrolyses the pyrophosphate
moiety of the lipid anchor (and of unused lipid II), leaving one
phosphate residue at the reducing end of the glycan strands.
Incubationwith amuramidase (cellosyl ormutanolysin) releases
the muropeptides, which are reduced with sodium boro-
hydride to change MurNAc to N-acetylmuramitol, followed by
HPLC analysis using a radioactivity flow-through detector
(figure 3d). Quantification of the separated muropeptide peaks
allows the calculation of the average length of the glycan strands,
the extent of peptide cross-linkageandwhetherhigheroligomers
such as trimers or tetramers are formed [103,104]. The assay also
detects possible CPase products, and allows themeasurement of
the effect of interacting proteins on TPase activity (see below).
7. GTase and TPase activities of class A
penicillin-binding proteins
Class A PBPs exhibit both GTase and TPase activities, which
is readily observed when such an enzyme polymerizes a
rstb.royalsocietypublishing.org
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producing a high-molecular weight fluorescent PG product
that barely enters the SDS–PAGE [95]. This product contains
polymerized glycan strands and peptide cross-links, and is
not obtained in samples containing a b-lactam blocking
TPase. However, this technique cannot quantify the extent
of cross-linking in the PG produced.
Both of the PG synthesis activities of class A PBPs have been
demonstrated with their natural substrate in vitro. PBP1A and
PBP1B of E. coli were capable of polymerizing lipid II to form
PG by the GTase–TPase assay with radiolabelled lipid II
(figure 3d) [103,104]. For PBP1A, the PG product contained
glycan strands approximately 20 disaccharide units in length
with approximately 18–26% of peptides present in cross-links
[104]. PBP1B was shown to be more active at conditions
which favour dimerization, and produced a PG product with
glycan strandsmore than 25 disaccharide units in length and
with approximately 50% of the peptides present in cross-links
[103]. Although these enzymes are semi-redundant in the cell
at standard laboratory conditions, there are differences in
their activities. In a time-course experiment studying PBP1A
activity, only GTase was observed within the first 15 min of
the reaction, with the consumption of approximately 25% of
the available substrate [104]. Significant TPase activity was
observed only after this initial period of glycan strand pro-
duction, suggesting that PBP1A requires pre-oligomerized or
high-molecularweight PG as acceptor for TPase reactions. Con-
sistent with this observation, PBP1A was able to attach
approximately 25% of the newly synthesized material to exist-
ing PG sacculi added to the reaction [104]. Attachment of the
new material occurred by TPase reactions, with monomeric
tri- and tetrapeptides in the sacculi acting as acceptors and
the pentapeptides of the newly made glycan strands acting as
donors. In contrast, PBP1B produced cross-linked material
from the onset of the reaction [103]. This difference may, in
part, be due to the dimerization of PBP1B, which was not
observed for PBP1A at the reaction conditions. A dimer of
PBP1B could potentially synthesize two glycan strands, which
could be simultaneously linked together by TPase reactions.
The coupling between GTase and TPase reactions is supported
by the crystal structure of PBP1B in complex with the GTase
inhibitor moenomycin, which occupies the GTase donor site
as does the nascent glycan strand. Its orientation suggests that
the growing glycan strand is produced such that peptides are
brought within range of the TPase active site [105].
Both PBP1A and PBP1B are able to catalyse the polymer-
ization of lipid II into glycan strands in the absence of TPase
activity, with the active site either blocked by b-lactam (e.g.
penicillin) or inactivated by mutation of the key catalytic
serine residue (PBP1A, S473; PBP1B, S510) [91,103,104]. In con-
trast, no or significantly reduced TPase activity is observed
when the GTase activity is blocked by inhibition with moeno-
mycin or by mutation of the key catalytic glutamate (PBP1A,
E94; PBP1B, E233), although the enzyme still binds b-lactam
antibiotic indicating a properly folded TPase site. Moreover,
the native enzyme does not significantly cross-link already
polymerized glycan strands (with monomeric peptides), and
mixing an inactive TPase version of PBP1B (capable of synthe-
sizing uncross-linked glycan strands) withGTasemutant (with
functional TPase site) does not result in significant TPase
activity. These data show that TPase activity of the bifunctional
PG synthases requires ongoing GTase activity in the samemol-
ecule of the enzyme [91,103,104] and is consistent with thePBP1B structure-based model that the growing glycan strand
produced by the GTase site of the enzyme delivers its peptides
in its TPase site for peptide cross-linking [105].8. Class A penicillin-binding proteins exhibit
carboxypeptidase activity
We have previously observed a low percentage of CPase pro-
ducts (muropeptides with monomeric tetrapeptides and
dimeric tetratetrapeptides, respectively) in the reaction pro-
ducts of E. coli PBP1A with lipid II, and CPase products
were enhanced in the presence of its regulator LpoA (see sec-
tion ‘Regulation of PBP activity’) [106]. Such an activity is
possible considering the similarity of the TPase domain of
class A PBPs with the CPase domain of class C PBPs, and
that the first step of both reactions involves the binding of
the same pentapeptide donor to the active site serine residue,
under release of the terminal D-alanine residue. TPases trans-
fer the enzyme-bound tetrapeptide to a peptide acceptor, and
CPases transfer the tetrapeptide to a water molecule releasing
the tetrapeptide from the enzyme.
We have now observed CPase activity for bothmajor E. coli
synthases, PBP1A and PBP1B, along with their previously
reported GTase and TPase activities [103,104]. CPase products
were significantly enhanced when PBP1A and PBP1B were
assayed with lipid II substrate in the presence of their cognate
Lpo protein, and at a mild acidic pH of 5.0 (peaks 2 and 4;
figure 4). Peak 2 corresponds to the monomeric disaccharide
tetrapeptide, and peak 4 to the dimeric bisdisaccharide tetrate-
trapeptide. Both these muropeptides arise from DD-CPase
activity and their formation is blocked by the specific inhi-
bition of PBP1A or PBP1B TPase with cefsulodin (figure 4),
which does not inhibit class C PBPs.
DD-CPase activity is normally associatedwith PG remodel-
ling hydrolases such as PBP5 [108]. These enzymes are thought
to play a role in regulating cell morphogenesis through limiting
the availability of pentapeptides as donor substrates for TPase
reactions, thus perhaps regulating the extent of cross-linkage in
the PG. Here, we propose that the class A PBPs are capable of
removing a tetrapeptide donor peptide bound to its active site
serine residue by CPase reactions. Such an ‘escape’ mechanism
would be required to resolve the acyl-enzyme complex if an
acceptor peptide is not available. In such a situation, an unre-
solved acyl-enzyme complex between the TPase active site
and a donor peptide would result in enzyme inhibition analo-
gous to inhibition by a b-lactam antibiotic. Hence, the CPase
activity of class A PBPs could release a donor peptide in the
absence of an acceptor, and this could be particularly impor-
tant when the enzyme’s TPase is stimulated with increased
donor binding, as might occur in the presence of Lpo proteins
(see section ‘Regulation of PBP activity’).9. Class A penicillin-binding proteins are active
when reconstituted in a membrane
ClassAPBPsare integralmembraneproteins andmust beactive
in the lipid bilayer of the cytoplasmic cell membrane. To mimic
such a lipidic environment, we have established a protocol to
reconstitute E. coli PBP1A and PBP1B in proteoliposomes
(large unilamellar vesicles, LUVs) containing polar phospholi-
pids from E. coli (figure 5a). These proteoliposomes contain
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Figure 4. Class A PBPs exhibit carboxypeptidase activity at pH 5.0. Representative examples of HPLC chromatograms from PG synthesis assay (figure 3d ) of PBP1B or
PBP1A with radioactive lipid II with and without their cognate Lpo at either pH 7.5 or 5.0, as indicated. The resulting PG was digested with muramidase (cellosyl)
yielding muropeptides, which were reduced with sodium borohydride and separated by HPLC. Radioactivity scale bars correspond to 500 cpm. Peak 1 corresponds to
monophosphorylated disaccharide pentapeptide, peak 2 to disaccharide tetrapeptide, peak 3 to disaccharide pentapeptide, peak 4 to bis-disaccharide tetratetrapep-
tide, peak 5 to bis-disaccharide tetrapentapeptide and peak 6 to tris-disachharide tetratetrapentapeptide [107]. Peaks 2 and 4 are the result of DD-CPase activity,
and are highlighted in red.
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quantitative degradation byproteinaseK,which canonlyaccess
outside-oriented protein (figure 5b). Hence, the orientation of
PBP in these liposomes is homogeneous and the same as in
the cytoplasmic membrane.
We next tested whether PBP1A and PBP1B present in pro-
teoliposomes were active in polymerizing radiolabelled lipid
II, which was added from the outside and inserted into the
liposomes. For this, samples were withdrawn after several
periods of time, and extracted by butanol/pyridine, which
does not extract the PG polymer, and quantified. Hence, the
assay measures the consumption of the radiolabelled lipid II
over time. Indeed, we could observe lipid II consumption for
both enzymes reconstituted into the liposomes (figure 5c). As
expected, the presence of ampicillin had no effect on lipid II
consumption by either enzyme, and moenomycin completely
inhibited both of them.10. Transpeptidase activity of class B penicillin-
binding proteins
Escherichia coli has two essential class B PBPs, PBP2 and PBP3,
which participate in and are required for cell elongation and
cell division, respectively. Cells depleted of PBP2 become
spherical owing to their inability to elongate, and cells depleted
of PBP3 grow filamentous as cell division is inhibited [109].
In class B PBPs, the N-terminal membrane anchor is linked to
a non-catalytic domain that functions as a ‘pedestal’ to place
the C-terminal TPase domain away from the cell membrane
and near the PG layer [110] (figure 1b). In PBP3 and presum-
ably other class B PBPs, the pedestal domain also stabilizes
the protein, is involved in the dimerization of the protein andprobably interacts with other proteins [111,112]. In E. coli,
PBP2 interacts with PBP1A and PBP1B interacts with PBP3
[48,113]. The crystal structures of several class B PBPs are
known, including the recently published structure of E. coli
PBP3 [112].
The TPase domain is similar in amino acid sequence and,
where known, structure to those of class A PBPs [4]. How-
ever, to observe an activity for a class B PBP with a natural
PG substrate has proved to be difficult. Recently, for the
first time, a TPase activity of a class B PBP was shown for
E. coli PBP2 [113]. Purified PBP2 bound the b-lactam anti-
biotic bocillin and bocillin binding was inhibited by pre-
incubating PBP2 with the specific antibiotic mecillinam, indi-
cating that the TPase domain was folded and active.
However, the purified enzyme alone did not cross-link lipid
II. PBP2 was also not active in the presence of a TPase-inac-
tive version of its interaction partner, class A PBP1A, which
was capable of synthesizing glycan strands, indicating that
ongoing glycan strand polymerization of PBP1A is not suffi-
cient to stimulate TPase activity of PBP2 [113]. PBP2
stimulated PBP1A’s GTase activity in different assays.
PBP1A is capable of attaching a fraction of newly synthesized
PG (from lipid II) to sacculi in vitro [104]. Interestingly, the
presence of PBP2 doubled the amount of the attached
material, and experiments using specific inhibitors for
PBP1A (cefsulodin) and/or PBP2 (mecillinam) proved that
PBP2 contributes to the attachment of new PG to sacculi by
virtue of its TPase activity [113]. Hence, PBP2 requires
ongoing PG synthesis by PBP1A and PG sacculi for activity,
illustrating the complex regulation and specificity of this
enzyme. Presumably, within the PBP1A–PBP2 complex, the
pentapeptides present in nascent glycan strands produced
by the GTase domain of PBP1A are used by the TPase
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Figure 5. Activity of PBP1A and PBP1B in a membrane environment.
(a) Incorporation of PBP1A and PBP1B into LUVs made of E. coli total lipid mix-
ture. Samples were taken at various stages of proteoliposome preparation and
resolved by SDS–PAGE followed by Coomassie blue staining. M, sample of
the mixture of LUVs and purified protein; S, sample of the supernatant resulting
from centrifugation of the mixture after detergent removal (Biobead treatment);
P, LUVs with PBP. (b) Proteinase K digests PBP1A and PBP1B present in LUVs,
suggesting that the PBPs were oriented outward. Untreated (–), proteolipo-
somes were pelleted by centrifugation without proteinase K treatment;
treated (K), proteoliposomes were incubated with proteinase K prior to centrifu-
gation; SDS extract (K/S), proteoliposomes were disrupted by SDS after proteinase
K treatment to release any protein that was facing the interior of the LUV. All
LUV-bound protein was accessible for proteinase K digestion, and no protein
was detected in the interior of the LUVs. (c) Consumption of [14C]lipid II by
PBP1A or PBP1B over time in LUVs. Amp, ampicillin; Moe, moenomycin.
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sacculi, attaching the new strand to the sacculi [113]. Such
reactions must occur in a growing cell, where new PG is
attached to the existing sacculus by TPase reactions
[114,115]. Similar to what we have described for E. coli
PBP2, it was recently shown that the class B PBPs from S.
pneumoniae, PBP2b and 2x, were active in TPase reactions in
the presence of a class A PBP (PBP2A) with active GTase
but mutationally inactive TPase domain [75]. Unlike E. coli
PBP2, the pneumococcal class B PBPs did not require the
presence of high-molecular weight PG for TPase activity.Escherichia coli PBP3 is active with thioester substrates,
either performing hydrolysis or transpeptidation with D-ala-
nine as acceptor [96,116]. However, to the best of our
knowledge, no TPase activity of PBP3 with a natural sub-
strate has been reported. In our hands, we were unable to
observe TPase of PBP3 with lipid II or polymerized glycan
strands in the presence or absence of PBP1B (ongoing
GTase reactions), FtsN (see below) and/or PG sacculi, despite
the ability of the purified PBP3 to bind b-lactam antibiotics
indicating a proper fold of the TPase domain (unpublished
data). Hence, it remains a conundrum what activates PBP3
in the cell. Possibly, PBP3 requires one or more yet unknown
interaction partners within the divisome (such as FtsQLB or
FtsW), or the particular membrane and PG architecture at
the tip of the septum for activity.11. Lipid II structure affects TPase activity
Inmany species, lipid II becomesmodified prior to its polymer-
ization. Many Gram-positive bacteria amidate the a-carboxylic
group of the iso-glutamic acid residue at position 2 of the pep-
tide by the amidotransferase MurT/GatD, which was
identified in S. aureus [73,74]. Other species such as B. subtilis,
Lactobacillus and Corynebacteriales amidate the 1-carboxylic
group of m-Dap by the enzymes AsnB1 and LtsA, respectively
[117,118]. Another modification is the attachment of amino
acid branches by Fem transferases which, upon TPase reac-
tions, lead to inter-peptide bridges [119].
Recent data show that the presence of modifications on
lipid II affect TPase activity. S. pneumoniae PBP2a did not
show TPase activity when using an unamidated lipid II
[95], but PBP2a and other pneumococcal PBPs (PBP1a,
PBP2b and PBP2x) showed TPase activity with the amidated
lipid II [75]. This indicates that lipid II amidation is a require-
ment for TPase activity. In contrast, B. subtilis PBP1 was
capable to perform TPase reactions, albeit to low extent,
with both amidated and unamidated lipid II [97].12. Regulation of penicillin-binding protein
activity
Bacteria regulate PG synthesis at multiple levels to balance PG
growth with the synthesis of other cell envelope layers and, in
general, with cell growth. One important aspect might be the
regulation of the synthesis rate and flux of the precursor lipid
II, which has to be flipped across the cytoplasmic membrane
to reach the PG synthases. The nature of the flippase is cur-
rently under debate. Purified FtsW/RodA flip lipid II in
liposomes [72,120], consistent with their essentiality for cell
division or elongation, their cellular localization and their inter-
actions with PG synthases [8]. Based on more indirect in vivo
data, MurJ was recently suggested to be the lipid II flippase
instead of FtsW [121], although purified MurJ does not exhibit
flippase activity [120].
Table 1 and figure 6 summarize factors that affect the activi-
ties of PG synthases. An important aspect of the regulation of
PG synthases are protein–protein interactions, of which sev-
eral are known to directly affect enzyme activities and
subcellular localization (figure 6). Here, we mainly focus on
the PG synthases of E. coli as these are the most studied.
Table 1. Known factors affecting the activity or regulation of PG synthases.
category examplesa with references
protein–protein
interaction
E. coli PBP1A—LpoA
— Essential for PBP1A function in the cell [106,122].
— Interaction stimulates the TPase activity: cross-links in PG product increases by 20% [106]; TPase rate (D-Ala
incorporation) increases sixfold with concomitant 1.5-fold increase in GTase rate [98].
E. coli PBP1A—PBP2 [113]
— Interaction stimulates the GTase reaction rate of PBP1A approximately fivefold and increases the mean glycan length.
— Interaction stimulates the TPase activity of PBP1A resulting in more efficient attachment of newly synthesized PG
to sacculi.
E. coli PBP1B—dimerization [103]
— Significantly stimulated GTase and TPase activities.
E. coli PBP1B—LpoB
— Essential for PBP1B function in the cell [106,122,123].
— Interaction stimulates the GTase approximately eightfold [123] and reduces the mean glycan chain length [98].
— Interaction stimulates the TPase resulting in 20% more cross-links in the PG product [106] and a 1.5-fold increase in
D-Ala incorporation rate [98].
E. coli PBP1B—FtsN
— Interaction stimulates PG synthesis activities of PBP1B at low concentration, possibly by promoting dimerization of
PBP1B [124].
— Stimulation of the GTase rate approximately fourfold, acts synergistically with LpoB (this work).
E. coli PBP2—PBP1A [113]
— Interaction stimulates the TPase activity of PBP2 for the attachment of newly synthesized PG to sacculi.
E. coli PBP1B-LpoB—CpoB/TolA [125]
— Interaction of CpoB partially prevents stimulation of TPase by LpoB, with a 50% reduction in stimulation.
— Interaction of TolA reverses the effect of CpoB on TPase and also stimulates GTase approximately 1.9-fold, acts
synergistically with LpoB.
V. cholerae PBP1A-LpoA—CsiV [126]
— DcsiV phenocopies DlpoA and DmrcA.
— CsiV interacts directly with LpoA and is essential for PBP1A function in the cell when grown in the presence of 5 mM
D-Met.
localization
or spatial regulation
E. coli PBP1B—PBP3 [48]
— PBP1B requires PBP3 for septal localization.
E. coli PBP3—FtsW [127]
— PBP3 requires FtsW for septal localization.
B. subtilis PBP1—GpsB/EzrA [128]
— PBP1 requires GpsB/EzrA for relocation from the side wall to the septum.
— GpsB removes PBP1 from new cell pole post-division.
precursor/substrate S. pneumoniae PBP1a, PBP2a, PBP2b, and PBP2x—amidation of lipid II [75]
— TPase activity requires the presence of an amidated iso-Gln residue at position 2 of the stem peptide.
S. aureus MtgA—lipid II [86]
— Binding of lipid II enhances the affinity of moenomycin to the glycan acceptor site.
environmental
conditions
C. crescentus PBP2 and PBP1A—osmolarity of growth medium [129]
— Upshift in the osmolarity of growth medium enhances localization to mid-cell relocating the PG growth site.
E. coli PBP1B and PBP1A—pH
— GTase activity is reduced at pH 4.5b [123].
— enhanced CPase activity at pH 5.0 (this work).
aSynthase shown in bold, regulator/effector underlined.
bOnly experimentally shown for PBP1B.
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Figure 6. Regulation of PG synthases in E. coli through protein–protein
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figure is supplementary to table S1 which contains the references. An
example of regulation in Vibrio cholerae which is not found in E. coli is
also shown, distinguished by (Vibrio). Black lines: direct interaction. Blue
arrow: recruitment to subcellular location, with the direction indicating the
protein recruited. Green arrow: stimulatory effect with the direction indicating
the affected synthase, the particular affected activity (GT and/or TP) is also
indicated. Red arrow: negative modulation of PBP1B-LpoB TPase by CpoB,
which is reversed by TolA as indicated by the capped black line. Grey-
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cellular function of class A PBPs
In E. coli, it was recently found that both major PG synthases
require cognate OM lipoproteins for function in the cell.
LpoA and LpoB are essential for the activities of PBP1A and
PBP1B, respectively [106,122]. The cell requires either PBP1A-
LpoA or PBP1B-LpoB for growth, with the depletion of one
of the lpo genes in the absence of the other resulting in cell
lysis, mirroring the phenotype of their cognate PG synthase
mutants [106,122,130]. The Lpo proteins activate their cognate
PBP by direct interaction with a specific docking domain. The
Lpo proteins also show the same preference for subcellular
localization as their cognate PBP. PBP1A and LpoA preferen-
tially localize to the side wall, and PBP1B and LpoB localize
to the sidewall and are enhanced at the division site. However,
in contrast to its cognate PBP, the localization of LpoB requires
the activity of PBP3 as it is diminished in cells treated with the
PBP3-specific b-lactam aztreonam, presumably because LpoB
localization requires ongoing septal PG synthesis [106].
LpoB was shown to interact with a small non-catalytic
domain within PBP1B, called UB2H, situated between the
GTase and TPase domains (figure 1b), via a relatively large
interface [123]. The structure of full-length LpoB was solved
byNMRspectroscopy [123]. LpoBhas a small globularC-term-
inal domain,withinwhich is the interaction site for PBP1B, and
a long proline-rich unstructured N-terminal region. This flex-
ible, disordered region has a maximal length of 145 A˚
allowing LpoB to reach from the OM to interact with and acti-
vate its cognate synthase [123]. The structure of the globular
domain of LpoB from both E. coli and Salmonella enterica was
also solved by X-ray crystallography [131].
LpoA is larger and more rigid than LpoB and does not
rely on a long flexible region to reach from the OM to its cog-
nate synthase. Instead, LpoA adopts an elongated fold withtwo distinct domains [132]. The structure of the N-terminal
domain of LpoA was solved by NMR spectroscopy, and
found to comprise a series of 5 helix-turn-helix tetratricopep-
tide-repeat (TPR)-like motifs. TPR motifs are protein–protein
interaction modules implicated in multiprotein complex for-
mation and are found in all kingdoms of life [133,134]. The
C-terminal domain of LpoA from E. coli has two extended
flexible regions of unknown function that presumably pre-
vent crystallization [132]. However, the structure of the
C-terminal domains from Haemophilus influenzae LpoA,
which lacks these regions, was solved showing similarity to
periplasmic binding protein domains [135]. SAXS, AUC
and NMR data of full-length E. coli LpoA suggest that there
is no flexibility between the N- and C-terminal domains,
and that the overall shape of the molecule is extended,
giving it a length of approximately 140–150 A˚ [134]. This dis-
tance would be sufficient for LpoA to reach from the OM to
the inner membrane (IM)-anchored PBP1A. PBP1A contains a
small non-catalytic domain, called ODD, which co-occurs
with LpoA in the g-proteobacteria. The overexpression of iso-
lated ODD domain into the periplasm of E. coli lacking
PBP1B or LpoB, therefore reliant on PBP1A-LpoA for
growth, caused lysis [106]. This suggested that the expressed
ODD competed with PBP1A for binding to LpoA and, hence,
that ODD is the docking domain for LpoA [106]. Analysis of
the primary sequence of class A PBPs from several species
revealed the presence of amino acid regions outside the cata-
lytic domains. These were often specific to closely related
group(s) of bacteria, and it was hypothesized that many of
these regions are docking domains for regulatory inputs [8].
(b) Activation of penicillin-binding proteins by Lpo
proteins
Both Lpo proteins directly affect the PG synthesis activities of
their cognate PBP in vitro. In both cases, the TPase activity is
stimulated, increasing the percentage of peptides in cross-
links by approximately 20% when using lipid II as substrate
[106]. LpoB also reduces the length of the glycan strands
produced by PBP1B (in the absence of TPase reactions). How-
ever, these end-point assays measured the product formed,
and could not determine any possible change in TPase or
GTase rate. Subsequently, it was shown that Lpo proteins
increase the TPase rate of their cognate PBP using the incorpor-
ation of radiolabelled D-Ala as proxy for TPase activity [98]. The
GTase and TPase activities of class A PBPs are coupled, with
TPase activity dependent upon ongoing GTase (discussed
above), raising the following question: do the Lpo proteins
stimulate one enzymatic activitywhich concomitantly increases
the other, or do they affect both simultaneously? This remains
largely unclear and recent data suggests that the primary stimu-
latory mechanism differs between LpoA and LpoB [98].
In addition to enhancing TPase activity, LpoAwas shown
to mildly enhance the rate of PBP1A GTase activity approxi-
mately 1.5-fold using the D-amino acid incorporation assay
(figure 3d ) [98]. Interestingly, this stimulation is blocked
by addition of penicillin G, suggesting that the GTase stimu-
lation requires enhanced TPase activity [98]. Using this assay
LpoB was also shown to enhance PBP1B GTase approxi-
mately 1.5-fold, but this was not blocked by penicillin
G. Thus, the authors suggest that LpoA primarily affects
the TPase activity of PBP1A, and LpoB the GTase activity
of PBP1B, which concomitantly affects the other domain
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and dansyl lipid II as substrate, LpoB’s stimulation of the
PBP1B GTase activity was shown to be approximately eight-
fold and independent of TPase reactions [123]. In this assay,
LpoB could rescue PBP1B GTase activity at a pH of 4.5, at
which the enzyme alone was virtually inactive. Thus, we
hypothesize that LpoB-binding to the UB2H domain of
PBP1B may cause an allosteric effect on the GTase domain,
inducing conformational change within the GTase catalytic
site leading to activation [123]. However, our current under-
standing of the regulatory mechanisms of the Lpo proteins
remains incomplete owing to limitations of the available
assays and the lack of co-structures of the complexes.
(c) The cell division protein FtsN stimulates PBP1B
GTase activity
FtsN is an essential division protein recruited to mid-cell
prior to the onset of constrictive PG synthesis [136]. It inter-
acts with other essential division proteins FtsA, FtsQ, PBP3
and FtsW (summarized in reference [137]). FtsN is a bitopic
membrane protein with a short cytoplasmic region, a single
transmembrane helix and a flexible periplasmic region
which features three a-helices followed by a proline/gluta-
mine-rich unstructured region and a globular C-terminal
SPOR domain which binds to PG but is not essential
[138,139]. Extensive mutagenesis showed that only three
amino acid residues (W83, Y85 and L89) in the periplasmic
part are critical for FtsN function [140]. FtsN may be involved
in the transduction of a signal from the late to the early divi-
some, to begin cytokinesis after the maturation of the
complex. Mutations in ftsQLB and ftsA could bypass the
need for FtsN, and the altered proteins acted synergistically
to restore cell division in its absence [140].
Different versions of purified FtsN interacted with PBP1B,
including full-length FtsN, a soluble version lacking the
cytoplasmic and transmembrane region, and several trunca-
tions of this soluble version, suggesting that there are
several interaction sites [124]. Interestingly, the full-length
protein containing the transmembrane and cytoplasmic
region stimulated the PG synthesis activity of PBP1B at con-
ditions where it did not dimerize and was poorly active.
Hence, we hypothesized that FtsN is capable of promoting
dimerization of PBP1B, enhancing its activities [103,124].
We have now used the continuous GTase assay with
dansyl-lipid II to assess the effect of FtsN on PBP1B activity.
Full-length FtsN-His stimulated the GTase activity of PBP1B
4.2+0.5-fold (figure 7a). Consistent with our previous data
[124], FtsN lacking the transmembrane and cytoplasmic
domains (FtsND1–57-His) had no effect, and FtsN-His alone
hadno effect on the fluorescent lipid II (figure 7a). Interestingly,
the stimulation of the GTase of PBP1B by FtsN was synergistic
with the stimulation by LpoB (figure 7a). With FtsN and LpoB,
the GTase rate increased 16.9+0.9-fold, more than with either
LpoB (9.3+0.9-fold) or FtsN (4.6+0.4-fold) alone. Because it
was possible that two subpopulations of enzymatically active
complexes exist within the reaction (PBP1B-LpoB and PBP1B-
FtsN), we sought to determine whether LpoB and FtsN are
able to interact simultaneously with PBP1B in a pull-down
assay using FtsN-His with PBP1B and LpoB, exploiting the
fact that LpoB and FtsN do not interact directly. Indeed,
untagged LpoB (soluble version) was retained by FtsN-His
on Ni-beads only in the presence of PBP1B (figure 7b),suggesting that both regulators bind to PBP1B simultaneously
to exert a synergistic effect on activity.
Together, these data suggest that FtsN ensures coordi-
nation of PG synthesis with cytokinesis through multiple
interactions with PG synthases and cell division proteins
and a direct stimulation of PBP1B activity.
(d) PBP3 has no effect on the glycosyltransferase
activity of PBP1B
FtsN interacts with both PBP1B and PBP3, and the synthases
also interact directly with each other [48]. Here, we tested
whether PBP3 may play a role in the regulation of the
GTase activity of PBP1B. Using the continuous GTase assay
with dansyl-lipid II as substrate, we found that PBP3 had
no effect on PBP1B GTase activity directly, nor did it
impact the stimulation by FtsN (figure 7a). Additionally,
His-PBP3 did not have an effect on the stimulation of
PBP1B by LpoB (figure 7a).
(e) Coordination of peptidoglycan synthesis with outer
membrane constriction in Escherichia coli
Recently, the stimulation of PBP1B by LpoB was found to be
modulated by proteins of the Tol system [125]. The Tol
system in E. coli features three IM-anchored proteins, TolA,
TolQ and TolR, which form a complex [141]. TolQ and TolR
are able to harness the proton motive force (pmf) to energize
TolA, driving conformational changes in its periplasmic
domains, which is required for function [142]. The Tol system
also includes a periplasmic protein, TolB, which interacts
with the C-terminal domain of TolA and with the abundant
PG-binding OM lipoprotein Pal [143], the final core member
of the system. Depleting the cell of any of the five components
leads to a tol–pal phenotype, typically exhibiting as severe
defects in OM stability and a delayed onset of constriction
during cell division [144]. Consistent with this, each of the
core Tol proteins localizes to mid-cell during cell division
dependent on the divisome complex [144].
TolA interacts with CpoB (formerly YbgF) [145] whose cel-
lular role was unclear, as a cpoBmutant did not show a tol–pal
phenotype. Recently, both TolA and CpoB were shown to
interact directly with PBP1B-LpoB in vitro and in the cell
[125]. Additionally, CpoB was found to localize to mid-cell at
the onset of constriction, requiring a functional divisome com-
plex. CpoB binds to PBP1B between the UB2H and TPase
domains. Consistent with this binding site, CpoB partially inhi-
bits the stimulation of the TPase activity of PBP1B by LpoB
in vitro. Remarkably, this effect of CpoB is relieved by TolA,
which interacts with PBP1B at the region proximal to the mem-
brane. TolA alone or with CpoB moderately enhances the
GTase of PBP1B (1.9+0.5-fold), and this effect is synergistic
with the stronger stimulation by LpoB. Furthermore, the inter-
actions of TolA and CpoB with PBP1B-LpoB are responsive to
the assembly of the Tol complex and its energy state in the cell.
No direct interaction was detected between CpoB and LpoB
either in vitro or in wild-type cells. However, in the absence
of tolA, tolQ or tolR a strong association between CpoB and
LpoB is seen in the cell, probably through PBP1B. This is also
seen in a strain with a point mutation in tolR preventing
TolQRA from harnessing the pmf. Thus, the modulation of
the TPase of PBP1B-LpoB by TolA and CpoB depends on the
state of the Tol system, and the functional link between these
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Figure 7. LpoB and FtsN synergistically enhance the GTase activity of PBP1B. (a) GTase activity of PBP1B was assayed by consumption of fluorescently labelled lipid
II in vitro. Change in GTase rate is relative to PBP1B alone at the indicated reaction conditions and is shown as the mean+ s.d. (n ¼ 4–12). Reaction conditions
(Triton X-100 (TX-100) concentration, temperature and enzyme concentration) were optimized for each experiment. Specific conditions are indicated above the
corresponding data. (b) A ternary complex of FtsN-PBP1B-LpoB was detected by in vitro cross-linking/pulldown approach. Proteins were cross-linked and applied
to Ni-NTA beads. Cross-linkage of bound proteins was cleaved and samples separated by SDS–PAGE and visualized with Coomassie blue. FtsN-His retained LpoB only
in the presence of PBP1B. The relatively weak retention of LpoB by PBP1B also occurs in the absence of FtsN, using His-PBP1B instead. This may be due to poor
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with OM constriction during cell division [125].( f ) CsiV regulates PBP1A-LpoA in Vibrio
The regulation of PBP1A by LpoA inVibrio cholerae involves an
additional factor [126], the small, periplasmic protein CsiV,
which was discovered by a chemical synthetic lethal screen.
A csiV deletion closely phenocopied mrcA (encoding PBP1A)
and lpoA deletions, and CsiV interacted directly with LpoA
in the cell. LpoA, mrcA and csiV are essential for growth in
the presence of 5 mM D-methionine. These strains also have
an altered PG content, particularly in stationary phase. How-
ever, while evidence suggests CsiV is important for the
function of PBP1A-LpoA it is not strictly essential; a csiV lpoB
double mutant, which relies on PBP1A-LpoA, is viable. Thus,
the precise role of CsiV remains to be determined [126].(g) Regulation of penicillin-binding protein localization
Escherichia coli PG synthases interact with several cell morpho-
genesis proteins and regulators (summarized in references
[8,137]), and some of these interactions appear to be required
to localize PBPs to the elongasome and divisome, respectively.
For example, PBP3 and PBP1B interact in non-dividing
cells [48], and PBP3 is recruited (presumably together with
PBP1B) to the divisome by interactions with FtsQLB
and FtsW. In other species, there can be variations in the
interactions and the divisome recruitment pathway (e.g. in
Caulobacter crescentus [146]).
The Gram-positive B. subtilis has additional factors to the
system of distinct, cytoskeleton controlled, elongation and
division complexes for spatial regulation of PG synthesis.
EzrA and GpsB control the localization of the major PG
synthase PBP1 during the cell cycle [128]. EzrA is the first
example of a bacterial spectrin-like protein, with an arc-like
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EzrA contributes to membrane-anchoring of FtsZ, regulating
its dynamics. Cells lacking EzrA formed aberrant, multiple Z-
rings and showed a delay in division [148]; a gpsB ezrA
double mutant has more severe cell division defects with
aberrant bulges at cell poles and division sites. A network
of interactions between PBP1 and GpsB, MreC (MreB-associ-
ated protein) and EzrAwas observed by bacterial two-hybrid
assays, indicating that PBP1 interacts with cell elongation and
division proteins consistent with its localization pattern [128].
GpsB functions to recruit PBP1 from the elongation to the
division complex and also removes PBP1 from the new cell
poles after division, making it available for elongation, a
function which is seemingly crucial in the B. subtilis cell
cycle [128].
In some species, the cellular localization of PG synthases
can also be regulated by environmental conditions. In
C. crescentus, even small osmotic upshifts cause PBP1A and
PBP2 to relocate, moving from a patchy side wall location
to the position of FtsZ at mid-cell [129]. While the relocation
of PBPs occurs within minutes, the restoration of their normal
side wall localization pattern requires cell growth and takes
one to two generations. This phenomenon appears to be
specific for C. crescentus, as the localization of PBPs in
E. coli was largely unaffected by an osmotic up-shift [129].13. Concluding remarks
How bacteria synthesize PG and expand their sacculus to
grow and divide, and how the process is regulated and coor-
dinated with the synthesis of other cellular components, have
remained highly fascinating but yet unanswered questions in
microbiology. Nonetheless, the past decade brought substan-
tial increase in our knowledge of PG synthesis, which was
made possible by the improvement of tools available, like
the different lipid II versions and novel in vitro PG synthesis
assays. Major recent advances were the discoveries of inter-
actions between PG synthases and other proteins that
influence GTase and/or TPase activities. We are beginning
to get an idea of the multiplicity and complexity of PG syn-
thesis regulation. With further technical advances and
increasing knowledge of all the components involved we
should be able to dissect the molecular mechanisms of bac-
terial cell wall growth. We hope that understanding this
fundamental process will also help to identify novel targets
for antimicrobial drug discovery.14. Material and methods
(a) Chemicals and proteins
[14C]GlcNAc-labelled lipid II and dansylated lipid II were prepared
as published [63,103]. The following proteins were prepared as
previously described: PBP1B [48], PBP1A [104], LpoB(sol) [123].
PBP3, FtsN and FtsND1–57 were overproduced using previously
published strains and plasmids [48,139] with modifications to the
purification procedure (below).
(b) Protein overproduction and purification
FtsN-His. Cells of BL21(DE3) pFE42 [139] were grown in 2 l of LB
medium with 100 mg ml21 ampicillin at 378C to an OD578 of 0.4.
FtsN-His was overproduced by adding 1 mM IPTG to the cellculture followed by a further incubation for 2 h at 378C. Cells
were harvested by centrifugation (10 000g, 15 min, 48C), and the
pellet was resuspended in buffer I (25 mM Tris/HCl, 1 M NaCl,
pH 6.0). A small amount of DNase, protease inhibitor cocktail
(Sigma, USA, 1/1000 dilution) and 100 mM phenylmethylsulfo-
nylfluoride (PMSF) was added before cells were disrupted
by sonication (Branson Digital, USA). The lysate was centrifuged
(130 000g, 1 h, 48C). The resulting membrane pellet was resus-
pended in extraction buffer (25 mM Tris/HCl, 1 M NaCl, 40 mM
imidazole, 1% Triton X-100, pH 6.0) and incubated overnight
with mixing at 48C. The sample was centrifuged (130 000g, 1 h,
48C) and the supernatant applied to a 5 ml HisTrap HP column
(GE Healthcare, USA) attached to an A¨KTA Primeþ (GE Health-
care, USA), at 1 ml min21. The column was washed with four
volumes extraction buffer, followed by four volumes of wash
buffer I (25 mM Tris/HCl, 1 M NaCl, 40 mM imidazole, 0.25%
Triton X-100, pH 6.0). Bound protein was eluted step-wise with
elution buffer (25 mM Tris/HCl, 1 M NaCl, 400 mM imidazole,
0.25% Triton X-100, pH 6.0). FtsN-His was dialysed into storage
buffer (25 mM Tris/HCl, 500 mM NaCl, 0.25% Triton X-100, 10%
glycerol, pH 6.0) and stored in aliquots at 2808C.
FtsND1–57-His. Cells of BL21-A1 pHis17-ECN2 [139] were
grown in 2 l of LB medium supplemented with 100 mg ml21
ampicillin at 308C to an OD578 of 0.5. FtsN
D1–57-His was overpro-
duced by adding 0.2% arabinose to the cell culture followed by a
further incubation for 3 h at 308C. Cells were harvested by cen-
trifugation (10 000g, 15 min, 48C) and the pellet was
resuspended in buffer I (25 mM Tris/HCl, 500 mM NaCl, pH
6.0). A small amount of DNase, protease inhibitor cocktail
(Sigma, 1/1000 dilution) and 100 mM PMSF was added before
cells were disrupted by sonication (Branson Digital, USA). The
lysate was centrifuged (130 000g, 1 h, 48C). The resulting super-
natant was applied to 1.5 ml of Ni-NTA superflow beads
(Qiagen, The Netherlands), supplemented with 10 mM imida-
zole and incubated for 18 h at 48C. Beads were washed with
7  10 ml wash buffer (25 mM Tris/HCl, 500 mM NaCl,
20 mM imidazole, pH 6.0) and bound protein eluted with 10 
1 ml elution buffer (25 mM Tris/HCl, 500 mM NaCl, 300 mM
imidazole, pH 6.0). Appropriate fractions were pooled and dia-
lysed into storage buffer (25 mM HEPES/NaOH, 500 mM
NaCl, 10% glycerol, pH 6.0) and stored in aliquots at 2808C.
His-PBP3. Cells of XL1-Blue pMVR1 [48] were grown in 5 l of
LB medium supplemented with 5% glycerol and 20 mg ml21
chloramphenicol at 308C to an OD578 of 0.6. His-PBP3 was over-
produced by adding 0.05 mM IPTG to the cell culture followed
by a further incubation for 18 h at 308C. Cells were harvested
by centrifugation (10 000g, 15 min, 48C) and the pellet was resus-
pended in buffer I (25 mM HEPES/NaOH, pH 8.0) before
another centrifugation step (as previous). The cell pellet was
resuspended in buffer II (25 mM HEPES/NaOH, 1 M NaCl,
pH 8.0) and a small amount of DNase, protease inhibitor cocktail
(Sigma, 1/1000 dilution), and 100 mM PMSF was added before
cells were disrupted by sonication (Branson Digital). The lysate
was centrifuged (130 000g, 1 h, 48C). The resulting membrane
pellet was resuspended in extraction buffer (25 mM HEPES/
NaOH, 10 mM MgCl2, 1 M NaCl, 20 mM imidazole, 2% Triton
X-100, pH 8.0) and incubated overnight with mixing at 48C.
Sample was centrifuged (130 000g, 1 h, 48C) and the supernatant
applied to 1 ml of washed Ni-NTA superflow beads (Qiagen, The
Netherlands). The sample was incubated with mixing for 4 h at
48C. Beads were then washed with 3  10 ml wash buffer I
(25 mMHEPES/NaOH, 10 mMMgCl2, 1 M NaCl, 20 mM imida-
zole, 0.2% Triton X-100, pH 8.0), followed by 4  10 ml wash
buffer II (as wash buffer I, with 40 mM imidazole and 10% gly-
cerol). Bound protein was eluted with 10  1 ml elution buffer
(25 mM HEPES/NaOH, 10 mM MgCl2, 1 M NaCl, 400 mM imi-
dazole, 10% glycerol, 0.2% Triton X-100, pH 8.0). Appropriate
fractions were pooled and dialysed into storage buffer (25 mM
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Triton X-100, pH 8.0) and stored in aliquots at2808C. The purified
His-PBP3 was able to bind the fluorescent b-lactam bocillin
(Molecular probes, USA) suggesting correct folding of the TPase
domain (not shown).
(c) Preparation of proteoliposomes wih PBP1A and
PBP1B
LUVs containing PBP1A or PBP1B were prepared according to
previously described methods with modifications [149–151]. A
total of 10 mg E. coli total lipid mix (Avanti Lipids, USA) was
dried in a glass test tube under a stream of nitrogen gas. The
resulting lipid film was further dried under vacuum in a desicca-
tor for 2 h. Lipids were then rehydrated to a concentration of
10 mg ml21 by the addition of 1 ml of 20 mM HEPES/NaOH,
100 mM NaCl pH 7.5. The resulting hydrated lipids are mainly
in the form of multilammellar vesicles. The vesicles were
freeze–thawed 10 times using liquid nitrogen and a water bath
set at 428C and were then extruded 10 times through a 0.2 mm
Anatop-10 inorganic membrane filter (Whatman (GE Health-
care), USA). At this point, nearly all the vesicles present were
unilamellar vesicles [150]. The size of the LUVs formed was con-
firmed by dynamic light scattering (DLS) using a Zetasizer
instrument (Malvern Technologies, UK). PBP1B or PBP1Apurified
in the presence of Triton X-100 and with a final concentration of
1.5 mM was added to 350 ml LUVs and incubated for 1 h at 48C
with rotary mixing. Wet prewashed Biobeads SM2 (100 mg;
BioRad, USA) were added to the sample. Biobeads were then
exchanged after 2 and 16 h, followed by incubation with fresh
Biobeads for a further 2 h. Biobeads were removed by centrifu-
gation at 4000g, and the supernatant was centrifuged at 250 000g
for 30 min at 48C. The resulting pellet containing the PBP-proteo-
liposomes was resuspended in 200 ml of 20 mM HEPES/NaOH,
100 mM NaCl, pH 7.5. Incorporation of the PBPs into LUVs was
tested by comparison between the pellet and supernatant after
the 250 000g centrifugation by SDS–PAGE, with Coomassie blue
staining (figure 5a). To test the orientation of the proteins within
the proteoliposomes, the samples were treated with 0.5 mg ml21
proteinase K for 15 min at 378C followed by centrifugation to
pellet the LUVs. The resulting pellets were boiled in SDS–PAGE
sample buffer and analysed by SDS–PAGE, following by staining
with Coomassie blue. A negative control featured disruption of the
LUVs with 0.5% SDS prior to proteinase K treatment. This exper-
iment showed that the PBPs are attached almost exclusively to
the outer leaflet of the LUV bilayer (figure 5b).
(d) Penicillin-binding protein activity assays in
detergent solution and proteoliposomes
The in vitro PG synthesis assay for the observation of CPase
activity of PBP1A and PBP1B was performed as previously
described [152], except that 10 mM sodium phosphate, pH 5.0,was used in place of HEPES/NaOH, pH 7.5 in the reaction
buffer for samples tested at this pH; all other components
remained the same. Continuous fluorescence GTase assays
using dansylated lipid II were performed as described previously
[113] whereby the reaction conditions (Triton X-100 concen-
tration, temperature and enzyme concentration) were varied as
indicated in figure 5a. The lipid II consumption assay on LUVs
was performed as follows. Samples consisted of 1 mM of either
PBP1B or PBP1A in LUVs (comprising approx. 2.5 mg of
lipids) with 5 nM [14C]GlcNAc-labelled lipid II (15 000 dpm),
0.01% EtOH, 5 mM MgCl2, 100 mM NaCl in a final volume of
540 ml. Samples were incubated at 378C in a thermal microfuge
tube shaker at 800 r.p.m. Aliquots of the reaction mix (95 ml)
were taken at 0, 5, 10, 20 and 30 min. Un-reacted lipid II was
immediately extracted by addition of 200 ml of a 1 : 1 mixture
of butanol and 6 M pyridine–acetate, pH 4.2 [63]. Samples
were mixed and centrifuged at 5000g for 2 min. The butanol
phase (approx. 100 ml) was collected in a scintillation vial, 5 ml
Ecoscint A liquid scintillation cocktail (National Diagnostics,
USA) was added and the radioactivity was measured using a
HIDEX 300SL b-particle scintillation detector. Where indicated,
samples included 0.2 mg ml21 moenomycin (Hoechst, Germany)
or 0.1 mg ml21 ampicillin (Sigma, USA) to inhibit GTase and
TPase, respectively.
(e) In vitro cross-linking/pulldown assay
Proteins were mixed at appropriate concentrations (FtsN-His and
PBP1B, 1mM; LpoB(sol), 2 mM) in 200 ml of binding buffer
(10 mM HEPES/NaOH, 10 mM MgCl2, 150 mM NaCl, 0.05%
Triton X-100, pH 7.5). Samples were incubated at room tempera-
ture for 10 min before addition of 0.2% w/v formaldehyde
(Sigma, USA) and further incubation at 378C for 10 min. Excess
cross-linker was blocked by addition of 100 mM Tris/HCl, pH
7.5. Samples were applied to 100 ml of washed and equilibrated
Ni-NTA superflow beads (Qiagen, The Netherlands) and incu-
bated overnight at 48C, with mixing. The beads were then
washed with 6  1.5 ml wash buffer (10 mM HEPES/NaOH,
10 mM MgCl2, 500 mM NaCl, 50 mM imidazole, 0.05% Triton
X-100, pH 7.5) and boiled in SDS–PAGE loading buffer. Beads
were then removed by centrifugation and samples analysed by
SDS–PAGE. Gels were stained with Coomassie brilliant blue
(Roth, Germany).
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